Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
July 10, 2020
Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression
Abhrajeet V Roy, Michelle Thai, Bonnie Klimes-Dougan, et al.
Leukemia
|
June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
S Kumar, A Dispenzieri, M Q Lacy, et al.
Leukemia
|
January 15, 2011
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
P Kapoor, S V Rajkumar, A Dispenzieri, et al.
Journal of Natural Products
|
April 10, 2026
Multilevel Residual Complexity Analysis Reveals Origin of Nanomolar Antiviral Bioactives of "Isoquercitrin"
Daniela Rebollar-Ramos, Annie V Roy, J Brent Friesen, et al.
Leukemia
|
August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma
T E Witzig, K M Laumann, M Q Lacy, et al.
Blood Cancer Journal
|
March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
V Roy, A K Stewart, P L Bergsagel, et al.
Elife
|
October 31, 2017
Deep transcriptome annotation enables the discovery and functional characterization of cryptic small proteins
Sondos Samandi, Annie V Roy, Vivian Delcourt, et al.
Leukemia
|
January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
A K Stewart, P L Bergsagel, P R Greipp, et al.
Blood Cancer Journal
|
November 5, 2016
Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
A Paulus, S Akhtar, T R Caulfield, et al.
Molecular Phylogenetics and Evolution
|
March 5, 2018
Complex taxonomy of the 'brush tail' peregrine earthworm Pontoscolex corethrurus
S Taheri, S James, V Roy, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Journal of Psychopharmacology (Oxford, England)
|
July 10, 2020
Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression
Abhrajeet V Roy, Michelle Thai, Bonnie Klimes-Dougan, et al.
Leukemia
|
June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
S Kumar, A Dispenzieri, M Q Lacy, et al.
Leukemia
|
January 15, 2011
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
P Kapoor, S V Rajkumar, A Dispenzieri, et al.
Journal of Natural Products
|
April 10, 2026
Multilevel Residual Complexity Analysis Reveals Origin of Nanomolar Antiviral Bioactives of "Isoquercitrin"
Daniela Rebollar-Ramos, Annie V Roy, J Brent Friesen, et al.
Leukemia
|
August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma
T E Witzig, K M Laumann, M Q Lacy, et al.
Blood Cancer Journal
|
March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
V Roy, A K Stewart, P L Bergsagel, et al.
Elife
|
October 31, 2017
Deep transcriptome annotation enables the discovery and functional characterization of cryptic small proteins
Sondos Samandi, Annie V Roy, Vivian Delcourt, et al.
Leukemia
|
January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
A K Stewart, P L Bergsagel, P R Greipp, et al.
Blood Cancer Journal
|
November 5, 2016
Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
A Paulus, S Akhtar, T R Caulfield, et al.
Molecular Phylogenetics and Evolution
|
March 5, 2018
Complex taxonomy of the 'brush tail' peregrine earthworm Pontoscolex corethrurus
S Taheri, S James, V Roy, et al.
Page
of 10